180 related articles for article (PubMed ID: 9803426)
1. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.
Evans SM; Haney M; Levin FR; Foltin RW; Fischman MW
Neuropsychopharmacology; 1998 Dec; 19(6):499-516. PubMed ID: 9803426
[TBL] [Abstract][Full Text] [Related]
2. Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder.
Evans SM; Foltin RW; Fischman MW
Appetite; 1999 Jun; 32(3):331-49. PubMed ID: 10336792
[TBL] [Abstract][Full Text] [Related]
3. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
[TBL] [Abstract][Full Text] [Related]
4. Medical management of premenstrual dysphoric disorder.
Yonkers KA
J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
[TBL] [Abstract][Full Text] [Related]
5. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study.
Berger CP; Presser B
Obstet Gynecol; 1994 Sep; 84(3):379-85. PubMed ID: 8058235
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
Schmidt PJ; Grover GN; Rubinow DR
Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
Freeman EW; Sondheimer SJ; Rickels K
Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
[TBL] [Abstract][Full Text] [Related]
9. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
Smith S; Rinehart JS; Ruddock VE; Schiff I
Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
[TBL] [Abstract][Full Text] [Related]
10. Menstrual phase-independent retrieval deficit in women with PMS.
Keenan PA; Lindamer LA; Jong SK
Biol Psychiatry; 1995 Sep; 38(6):369-77. PubMed ID: 8547456
[TBL] [Abstract][Full Text] [Related]
11. Treatment of premenstrual dysphoria with alprazolam. A controlled study.
Harrison WM; Endicott J; Nee J
Arch Gen Psychiatry; 1990 Mar; 47(3):270-5. PubMed ID: 2407209
[TBL] [Abstract][Full Text] [Related]
12. Mood and cognitive style in premenstrual syndrome.
Rapkin AJ; Chang LC; Reading AE
Obstet Gynecol; 1989 Oct; 74(4):644-9. PubMed ID: 2797641
[TBL] [Abstract][Full Text] [Related]
13. A double-blind trial of four medications to treat severe premenstrual syndrome.
Diegoli MS; da Fonseca AM; Diegoli CA; Pinotti JA
Int J Gynaecol Obstet; 1998 Jul; 62(1):63-7. PubMed ID: 9722128
[TBL] [Abstract][Full Text] [Related]
14. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
Verster JC; Volkerts ER; Verbaten MN
Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
[TBL] [Abstract][Full Text] [Related]
15. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
[TBL] [Abstract][Full Text] [Related]
16. Premenstrual syndrome no progesterone; premenstrual dysphoric disorder no serotonin deficiency.
van Leusden HA
Lancet; 1995 Dec; 346(8988):1443-4. PubMed ID: 7490987
[No Abstract] [Full Text] [Related]
17. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
18. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
[TBL] [Abstract][Full Text] [Related]
19. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
Sundblad C; Hedberg MA; Eriksson E
Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
[TBL] [Abstract][Full Text] [Related]
20. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]